POD People: David Small
David has been with the NPOD Global team since August 2014 and has a wide-ranging role in ensuring the development of NGPOD meets the needs of patients and healthcare professionals and that every step of the design and manufacturing process meets regulatory requirements.
Meet David
David has a MSc in Analytical Bioscience & Drug Design and a background of working with the UK MHRA (Medicines & Healthcare Regulatory Authority) is ideally suited to ensuring submissions to the regulatory authorities in Europe (CE marking) and the USA (FDA 510k) are prepared to minimise the time to gain market authorisation.
More from the newsfeed
September 21, 2025
NGPOD Being Used in 20 Hospitals across United KingdomSeptember 14, 2025
NGPOD Selected for Health Innovation Network Momentum AcceleratorSeptember 7, 2025
NGPod Global at BAPEN 2025: Join us at ICC WalesSeptember 1, 2025
NGPOD to Showcase Next-Generation Digital pH Testing at HETT 2025WHAT IS NGPOD?
NGPod: Stop "Never Events", improve patient recovery and reduce costs
The NGPod handheld devices overcomes many of the risks associated with existing Nasogastric placement confirmation methods.
- No aspiration required
- No interpretation required. Get a clear "Yes/No" answer
- Rapid result [c.15 seconds]
- Reduce delays to patients treatment, hydration and nutrition
- More cost-effective than testing with pH strips
.jpg)
%20(1).jpg)
